Nipradilol
![]() | |
| Names | |
|---|---|
| IUPAC name
[8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate | |
| Identifiers | |
| 81486-22-8 | |
| 3D model (Jmol) | Interactive image |
| ChemSpider | 65005 |
| PubChem | 72006 |
| |
| |
| Properties | |
| C15H22N2O6 | |
| Molar mass | 326.35 g·mol−1 |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Nipradilol is a beta blocker and nitric oxide donor.[1]
References
- ↑ Inoue, K; Kei Noguchi, K; Masumoto, M; Wakakura, G (2011). "Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma". Clinical ophthalmology (Auckland, N.Z.). 5: 1211–6. doi:10.2147/OPTH.S23233. PMC 3180485
. PMID 21966188.
| Forms | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Targets |
| ||||||||||||||||||||||||
| NO donors (prodrugs) |
| ||||||||||||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||||||||||||
| Others |
| ||||||||||||||||||||||||
This article is issued from Wikipedia - version of the 5/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
